EW - Edwards Lifesciences Corporation

NYSE - Nasdaq Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 52.56B
Enterprise value 51.99B
Trailing P/E 35.98
Forward P/E 34.36
PEG ratio (5-yr expected) 4.28
Price/sales (ttm)9.77
Price/book (mrq)8.79
Enterprise value/revenue 9.45
Enterprise value/EBITDA 29.27

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-18.68%
S&P500 52-week change 31.77%
52-week high 3107.92
52-week low 367.13
50-day moving average 385.05
200-day moving average 382.11

Share statistics

Avg vol (3-month) 32.98M
Avg vol (10-day) 32.46M
Shares outstanding 5606.22M
Implied shares outstanding 6N/A
Float 8600.6M
% held by insiders 10.84%
% held by institutions 187.23%
Shares short (14 May 2023) 49.84M
Short ratio (14 May 2023) 43.66
Short % of float (14 May 2023) 41.64%
Short % of shares outstanding (14 May 2023) 41.62%
Shares short (prior month 13 Apr 2023) 412.62M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 331 May 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 27.06%
Operating margin (ttm)32.39%

Management effectiveness

Return on assets (ttm)13.04%
Return on equity (ttm)25.01%

Income statement

Revenue (ttm)5.5B
Revenue per share (ttm)8.94
Quarterly revenue growth (yoy)8.80%
Gross profit (ttm)4.3B
Net income avi to common (ttm)1.49B
Diluted EPS (ttm)2.42
Quarterly earnings growth (yoy)-8.90%

Balance sheet

Total cash (mrq)1.25B
Total cash per share (mrq)2.07
Total debt (mrq)687.8M
Total debt/equity (mrq)11.35
Current ratio (mrq)3.01
Book value per share (mrq)9.86

Cash flow statement

Operating cash flow (ttm)1.24B
Levered free cash flow (ttm)994.54M